Association between adherence to calcium-channel blocker and statin medications and likelihood of cardiovascular events among US managed care enrollees
Open Access
- 17 June 2010
- journal article
- Published by Springer Science and Business Media LLC in BMC Cardiovascular Disorders
- Vol. 10 (1), 29
- https://doi.org/10.1186/1471-2261-10-29
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Adherence level of antihypertensive agents in coronary artery diseaseBritish Journal of Clinical Pharmacology, 2009
- Can adherence to antihypertensive therapy be used to promote adherence to statin therapy?Patient Preference and Adherence, 2009
- Compliance with lipid-lowering therapy and its impact on cardiovascular morbidity and mortalityExpert Opinion on Drug Safety, 2008
- Adherence with multiple-combination antihypertensive pharmacotherapies in a US managed care databaseClinical Therapeutics, 2008
- Long‐term adherence to statin treatment in diabetesDiabetic Medicine, 2008
- Medication nonadherence is associated with a broad range of adverse outcomes in patients with coronary artery diseaseAmerican Heart Journal, 2008
- Medication Compliance and Persistence: Terminology and DefinitionsValue in Health, 2008
- Predictors of Adherence to Concomitant Antihypertensive and Lipid-Lowering Medications in Older AdultsDrugs & Aging, 2008
- Impact of adherence to statins on coronary artery disease in primary preventionBritish Journal of Clinical Pharmacology, 2007
- Hypertension Treatment and Control in Five European Countries, Canada, and the United StatesHypertension, 2004